✦ LIBER ✦

Final results of a phase III clinical trial on adjuvant intraportal infusion with heparin and 5-fluorouracil (5-FU) in resectable colon cancer (EORTC GITCCG 1983–1987)

✍ Scribed by D Nitti; J Wils; T Sahmoud; D Curran; M.L Couvreur; M Lise; H Rauschecker; J.Guimaraes dos Santos; W Stremmel; F Roelofsen

Book ID: 117663810
Publisher: Elsevier Science
Year: 1997
Tongue: English
Weight: 701 KB
Volume: 33
Category: Article
ISSN: 0959-8049
DOI: 10.1016/s0959-8049(97)00052-x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

3013 ORAL Tissue biomarkers in colon can

3013 ORAL Tissue biomarkers in colon cancer (COC): Early results of the translational study on a phase III trial comparing infused irinotecan/ 5-fluorouracil (5-FU)/folinic acid (FA) to 5-FU/FA in stage II–III COC patients (PETACC 3–EORTC 40993–SAKK 60/00)

✍ A. Roth; S. Tejpar; P. Yan; R. Fiocca; S. Hsu Schmitz; G. Bodoky; R. Labianca; D 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 60 KB

Phase 2 trial of primary systemic therap

Phase 2 trial of primary systemic therapy with doxorubicin and docetaxel followed by surgery, radiotherapy, and adjuvant chemotherapy with cyclophosphamide, methotrexate, and 5-fluorouracil based on clinical and pathologic response in patients with stage IIB to III breast cancer : Long-term results from The University of Texas M. D. Anderson Cancer Center Study ID97-099

✍ Ricardo H. Alvarez; Daniel J. Booser; Massimo Cristofanilli; Aysegul A. Sahin; E 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 199 KB 👁 2 views